Biomod/2013/Todai/Project: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
 
(20 intermediate revisions by the same user not shown)
Line 23: Line 23:
.rightbar-pro {
.rightbar-pro {
   font-size: 90%;
   font-size: 90%;
   width: 160px;
   width: 140px;
   background-color: #ffffff;
   background-color: #ffffff;
   padding: 8px;
   padding: 5px;
  padding-left:2px;
   position: fixed;
   position: fixed;
   top: 250px;
   top: 250px;
Line 73: Line 74:
<div class="rightbar-pro">
<div class="rightbar-pro">
   <ul>
   <ul>
     <li><a href="#Background and problem">Background&Problem</a>
     <li><a href="#Background and problem">Background&amp;Problem</a>
     </li>
     </li>
     <li><a href="#Solution">Solution</a>
     <li><a href="#Solution">Solution</a>
Line 106: Line 107:


       <p class="paragraph">
       <p class="paragraph">
      Cancer is one of the most malignant diseases. In cancer, cells get abnormal, divide and grow uncontrollably, forming malignant tumors, and invade human body. It accounts for about 13 percent of deaths in the world.
Cancer is one of the most common diseases in the world. Cancer cells divide abnormally and grow uncontrollably, resulting in the formation of malignant tumors, and invading human body. Cancer causes about 13 percent of the all human deaths worldwide (WHO 2007).
       </p>
       </p>
      <br>
      <br>
       <br>
       <br>
       <br>
       <br>
Line 129: Line 128:


       <p class="paragraph">
       <p class="paragraph">
      One of the most effective medical treatments for cancer is chemotherapy, but it often has severe side effects. This is because anti-cancer drugs attack not only cancer cells but also normal cells, damaging normal tissue and organs. According to <a href="http://www.cancer.org/" style="color:#e00000;">the American cancer society</a>, these side effects include pain, vomiting, limphedemia, sexual decline and various symptoms, which seriously decrease quality of life.
Chemotherapy is a popular medical treatments for the cancer, however, it often attacks normal cells in addition to the cancer cells, damaging normal tissue and organs, which cause severe side effects. According to <a target="_blank" href="http://www.cancer.org/" style="color:#e00000;">the American cancer society</a>, these side effects include pain, vomiting, limphedemia, sexual decline and various symptoms, which seriously decrease quality of life.
       </p>
       </p>
       <br>     
       <br>     
      <br>
       <br>
       <br>
       <br>
       <br>
Line 147: Line 147:
       <br>
       <br>


<!--paragraph4-->
       <p class="paragraph">
       <p class="paragraph">
       To improve cancer-specificity, drug delivery system has also developed recently, but it is difficult to customize a delivery system one by one corresponding to each drug.
       To improve cancer-specificity, drug delivery system (DDS) has developed, but it is difficult to optimize a delivery system for each drug.
       </p>
       </p>
      <br>
       <br>
       <br>
       <br>
       <br>
Line 166: Line 168:
     <article>
     <article>
       <p class="paragraph" style="font-size:130%">
       <p class="paragraph" style="font-size:130%">
       Team Todai nanORFEVRE are trying to make <span style="font-weight:bolder;color:#e00000;">cancer-specific drug which doesn’t need delivery system</span>.
       Team Todai nanORFEVRE are trying to make <span style="font-weight:bolder;color:#e00000;">cancer-specific drug which doesn't need delivery system (DDS)</span>.
       </p>
       </p>
       <br>
       <br>
Line 173: Line 175:
         <center>
         <center>
           <img style="margin-top:0px;"
           <img style="margin-top:0px;"
           src="http://openwetware.org/images/b/bf/Bgp4-4-Todai.png" width=450px height=350px >
           src="http://openwetware.org/images/f/f2/Todai_project_back4.4.png" width=450px height=350px >
         </center>
         </center>
       </figure>
       </figure>
Line 199: Line 201:


       <p class="paragraph" style="font-size:105%;">
       <p class="paragraph" style="font-size:105%;">
      To realize a cancer-cell-killing system with high specificity, we first focused on a mechanism in the human immune system called membrane attack complex (MAC), which functions when bacteria infect our body. In the system of MAC, subunits penetrate the membrane, oligomerize, and form a pore through the bacteria membrane. Then the subunits disrupt the lipid bilayer and lead the targeted cells to lysis and die. Subunits show citotoxity only after forming a pore. They don’t kill the cell simply by penetrating it. Molecules on the surface of harmless cells prevent MAC from sticking in (and forming pores), so MAC will only show citotoxity to foreign cells such as bacteria.
To achieve a cancer-cell-killing system with high specificity, we first took attention to a mechanism in the human immune system called membrane attack complex (MAC), which operates when bacteria infect our body. In the system of MAC, subunits penetrate the membrane, oligomerize, and form a pore into the bacteria membrane. Then the subunits disrupt the lipid bilayer, inducing targeted cells lysis and death. The point of this system is that the subunits show cytotoxity only after forming a pore. MAC do not kill the cell simply by penetration, as molecules on the surface of harmless cells prevent MAC from sticking in (and forming pores). Therefore, MAC will only show cytotoxity to foreign cells such as bacteria.  
    </p>
    </p>
         <br>
         <br>
Line 209: Line 211:
     <article>
     <article>
       <p class="paragraph">
       <p class="paragraph">
      We decided to kill the (cancer) cells. But the natural cancer-recognition is far more complicated than referred above, in which a lot of molecules are related. So we had to device artificial approach for the cancer-recognition system. Actually, there is a research that tries to develop pore-forming proteins like MAC <span class="ref-sup"><a href="#proref-1">[1]</a></span>,but in that research they could not reach the point of discrimination.
However, the target-recognition of MAC is far more complicated than referred above, in which a lot of molecules are related. So it is much difficult to mimic the whole system, leading us to take a simple synthetic biological approach.  
       </p>
       </p>


       <figure>
       <figure>
         <center>
         <center>
           <img src="http://openwetware.org/images/2/2f/Solution3-2-Todai.png" width=450px height=350px >
           <img src="http://openwetware.org/images/f/f8/Todai_solution3.2.png" width=450px height=350px >
         </center>
         </center>
       </figure>
       </figure>
Line 225: Line 227:


       <p class="paragraph">
       <p class="paragraph">
      Then, we thought about using DNA for recognition system. In situ computation by DNA was reported in <i>Nature Nanotechnology</i>(Maria Rudchenko et al.(2013)).
In the previous study, Rausch et al. used peptides to develop pore-forming proteins like MAC <span class="ref-sup"><a href="#proref-1">[1]</a></span>,but in that research they could not recognize the specific cells. To achieve the recognition system, we thought about using DNA. Recently, in situ computation by DNA was reported (Maria Rudchenko et al. (2013).<span class="ref-sup"><a href="#proref-2">[2]</a></span> In that study, DNA was used as logic circuits: using surface antigens as inputs and generating DNA strands as outputs. Rudchenko et al. said that it may be possible to use their logic circuit for other self-assembling systems and DNA machinery. We, therefore, thought that it might be possible to make cancer-recognition system using DNA. Inspired by cell recognizing molecular nano-robot study (Douglass et al. (2012)<span class="ref-sup"><a href="#proref-3">[3]</a></span>, we used  <a href="http://openwetware.org/wiki/Biomod/2013/Todai/Design#2.2_Recognition_system" style="color:#e00000">DNA aptamer</a> to recognize cancer cells.
      <span class="ref-sup"><a href="#proref-2">[2]</a></span>
      </a>
      DNA was used as logic circuits which uses surface antigens as inputs and generates DNA strands as outputs. They said it may be possible to use this logic circuit for other self assembling systems and DNA machinery. By using DNA, we thought we can make cancer-recognition system.
       </p>
       </p>
       <br>
       <br>
       <br>
       <br>
Line 237: Line 239:
     <article>
     <article>
       <p class="paragraph">
       <p class="paragraph">
      Therefore, our general idea is explained as follows. Subunits stick in normal and cancer cells nonspecifically. Then only when cancer-specific antigens are expressed, DNA computing circuit puts out certain DNA strand. And this strand triggers oligomerization of the subunits and citotoxity is induced. To control oligomerization by DNA strand, we think several mechanisms. For example, using output strand in the toehold system
Our general idea is explained as follows. 1) Subunits stick in normal and cancer cells nonspecifically. 2) In case that cancer-specific proteins exist, OCKs get able to oligomerize. 3)Then subunits oligomerize and form a pore, and cytotoxicity is induced to the cancer cell. Overall, our subunits may oligomerize only on the cancer cells and kill only cancer cells.
      <span class="ref-sup"><a href="#proref-3">[3]</a></span>
      </p>
      that triggers hyblidization of subunits. Overall, subunits oligomerize only on the cancer cells and kill only cancer cells. We believe that our Oligomeric Cell Killer has the potential to treat cancer and other diseases like infection, and as the basis of DNA origami robotic system in which multiple molecules coordinate according to logic computation performed by DNA itself.
     
      <p class="paragraph">
DNA itself has information embedded in the sequence. Using DNA computation and DNA-protein hybrid system, in which multiple molecules coordinate, we believe that our "Oligomeric Cell Killer" has the potential to treat cancer and other diseases like infection.
       </p>
       </p>
       <br>
       <br>
Line 245: Line 249:
     <figure>
     <figure>
       <center>
       <center>
         <img src="http://openwetware.org/images/5/57/Solution3-3-Todai.png" width=450px height=350px >
         <img src="http://openwetware.org/images/c/c2/Todai_project_solution3.3.png" width=450px height=350px >
         </center>
         </center>
       </figure>
       </figure>
Line 264: Line 268:
     <article>
     <article>
       <p class="paragraph">
       <p class="paragraph">
      Our general idea can be divided into two steps, <span style="color:#e00000">cancer-recognition</span> and <span style="color:#e00000;">killing</span>. DNA computing circuit for recognition was developed in the past research<span class="ref-sup"><a href="#proref-2">[2]</a></span>, so we set the goal of the biomod 2013 <span style="font-weight:bolder;color:#e00000;">the development of pore-forming DNA origami for the killing system</span>. To achieve this goal, we thought about biomolecular robotic system named as Oligomeric Cell Killer explained in  
We set the creation of a prototype of<span style="color:#e00000"> the cancer-specific drug which doesn't need delivery system (DDS)</span> as the goal.To achieve this goal, we thought about biomolecular robotic system named as "Oligomeric Cell Killer" explained in <a target="_blank" href="http://openwetware.org/wiki/Biomod/2013/Todai/Design" style="color:#e00000">
      <a target="_blank" href="http://openwetware.org/wiki/Biomod/2013/Todai/Design"  
      style="color:#e00000">
       the Design page
       the Design page
       </a>.
       </a>.
       </p>
       </p>
      <br>


     </article>
     </article>
Line 279: Line 280:
     <article>
     <article>
       <p class="paragraph">
       <p class="paragraph">
       We can divide the project goal <b>"the development of pore-forming DNA origami for the killing system"</b> into following five steps.
       We can divide the project goal into following six steps.
       </p>
       </p>
       <br>
       <br>


     <ul class="project-list">
     <ul class="project-list">
       <li>DNA strands assemble to form designed structures.</li>
       <li>DNA strands assemble to form designed structures</li>
       <li>The formed subunits oligomerize in the solution.</li>
       <li>Penetration into the membrane</li>
       <li>Subunits stick in the membrane.</li>
      <li>Recognition of cancer-specific proteins</li>
       <li>Subunits oligomerize on the membrane.</li>
       <li>Oligomerization in solution</li>
      <li>Subunits form the pore and kill the cell.</li>
       <li>Oligomerization on the membrane</li>
<li>Pore-formation and killing of the cell</li>
     </ul>
     </ul>


     <figure>
     <figure>
       <center>
       <center>
         <img src="http://openwetware.org/images/8/8c/Projectgoals-new2-Todai.png" width="700px" height="500px" style="position:relative;left:-22px;" >
         <img src=" http://openwetware.org/images/4/4f/Projectsteps.png " width="750px" height="500px" style="position:relative;left:-42px;" >
         </center>
         </center>
       </figure>
       </figure>
Line 299: Line 301:
     <br>
     <br>


   
<!--paragraph3-->
<!--paragraph3-->
      <article>
      <p class="paragraph" style="font-size:110%;">
      <span style="color:#e00000">However</span>,
      our project remains still very complicated and before actually using Oligomeric Cell Killer in the experiments, we should know what conditions should be set. So we also designed
      <a target="_blank"
      href="http://openwetware.org/wiki/Biomod/2013/Todai/Design#CylinderinBarrel">
      <span style="color:#e00000">Cylinder in barrel by DNA origami as the simple model of Oligomeric Cell Killer</span></a>,
      and perform experiments referred above with it <span style="color:#e00000">first</span>.
      </p>
      </article>
    <br>
<!--paragraph4-->


       <article>
       <article>
Line 357: Line 343:
         </div>
         </div>
           <div class="reference-author">
           <div class="reference-author">
           Maria Rudchenko, Steven Taylor, Payal Pallavi, Alesia Dechkovskaia, Safana Khan, Vincent P. Butler Jr, Sergei Rudchenko & Milan N. Stojanovic
           Maria Rudchenko, Steven Taylor, Payal Pallavi, Alesia Dechkovskaia, Safana Khan, Vincent P. Butler Jr, Sergei Rudchenko &amp; Milan N. Stojanovic
           </div>
           </div>
               <div class="reference-journal">
               <div class="reference-journal">
               Nature Nanotechnology 8, 580–586 (2013) doi:10.1038/nnano.2013.142
               Nature Nanotechnology 8, 580-586 (2013) doi:10.1038/nnano.2013.142
               </div>
               </div>
     </div>
     </div>
    <br>
    <br>
     <div>     
     <div>     
         <div class="reference-title">
         <div class="reference-title">
         <a name="proref-3">
         <a name="proref-3">
         [3] Transcription Regulation System Mediated by Mechanical Operation of a DNA Nanostructure
         [3]A logic-gated nanorobot for targeted transport of molecular payloads.
         </a>
         </a>
         </div>
         </div>
           <div class="reference-author">
           <div class="reference-author">
          Masayuki Endo, Ryoji Miyazaki, Tomoko Emura, Kumi Hidaka, and Hiroshi Sugiyama
          Shawn M. Douglas, Ido Bachelet and George M. Church
           </div>
           </div>
               <div class="reference-journal">
               <div class="reference-journal">
              Journal of the American Chemical Society 2012 134 (6), 2852-2855
            Science. 2012 Feb 17;335(6070):831-4. doi: 10.1126/science.1214081.
               </div>
               </div>
     </div>
     </div>
    <br>
   </article>
   </article>
   <br>
   <br>

Latest revision as of 23:14, 26 October 2013

<html> <head> <meta name="viewport" content="width=1200">

<style> <!--

body{

 font-family:Verdana;
 Myriad Pro;
 Arial;
 background-color: #fffc77;
 overflow-y:scroll;
 overflow-x:hidden;
 }

article{

 background-color: #ffffff
 }

.Logo {

 position: relative;
 left: -39px;
 }

.zairyou-heading {

 font-size: 120%;
 position: relative;
 left:30px;
 line-height: 2.2;
 }

.zairyou-heading-sub {

 font-size: 110%;
 position: relative;
 left:30px;
 line-height: 2.2;
 }

.zairyou-list {

 font-size: 100%;
 position: relative;
 left: 40px;
 }

p.paragraph{

 font-size :110%;
 line-height:1.5;
 margin:0 20px;
 text-indent: 1em;
 }

p.noindent-paragraph {

 font-size :110%;
 line-height:1.5;
 margin:0 20px;
 }

p.item {

 font-size :110%;
 line-height:1.5;
 margin:0px 20px;
 text-indent: 2em;
 }

h1.title a{

 font-size :90%;
 font-style:italic;
 display: block;
 text-decoration: none;
 color: #000000;

 font-weight:bolder;

 border-left: solid 5px #e00000 
 }

h1.big-title a{

 font-size :110%;
 display: block;
 text-decoration: none;
 color: #000000;

 font-weight:300;

 }

h1.heading a{

 font-size :95%;
 display: block;
 text-decoration: none;
 color: #000000;

 font-weight:100;

 border-left: solid 7px #ffa500
 }

h2.small-title a{

 font-size :100%;
 display:block;
 text-decoration: none;

 font-weight:bolder;

 color: #e00000;
 }

.sidebar {

 font-size: 110%;
 width: 110px;
 background-color: #ffffff;
 padding: 7px;
 position: fixed;
 top: 167px;
 left: auto;
 z-index: 20;
 margin: 0 0 0 -175px;
 border:solid 1.5px orange;
 }

.sidebar ul {

 position:relative;
 top:-3px;
 left:-3px;
 }

.sidebar ul li ul {

 list-style: none;
 position: relative;
 left: -15px
 }

.sidebar ul li ul li a{

 font-size: 85%;
 }

a:link {color:#000000;} a:visited {color:#000000;} a:hover {color:#e00000;} a:active {color:#e00000;}

.Return-Logo a{

 position: fixed;
 bottom: 10px;
 left: auto;
 margin: 0 0 0 789px;
 z-index: 20;
 display:block;
 width:60px;
 height:0px;
 padding-top:60px;
 background:url(http://openwetware.org/images/b/b1/Return-top-0828new.png);
 overflow:hidden;
 }

.Return-Logo a:hover {

 background-position: left bottom;
 }

.reference-title a{

 color:#000000;
 font-size:110%;
 font-weight:bolder;
 text-decoration:none;
 }

.reference-author {

 font-size:110%;
 position:relative;
 left:30px;
 }

.reference-journal {

 font-size:110%;
 font-style:italic;
 position:relative;
 left:30px;
 }

.ref-sup a{

 vertical-align:super;
 color:#e00000;
 text-decoration:none;
 }
  1. column-one { display:none; width:0px;}

.container{background-color: #ffffff; margin-top:0px} .OWWNBcpCurrentDateFilled {display: none;}

  1. content { width: 0px; margin: 0 auto auto 0; padding: 0em 0em 0em 0em; align: center;}
  2. column-content {width: 0px; float: left; margin: 0 0 0 0;padding: 0;}

.firstHeading {display:none; width:0px;}

  1. globalWrapper{width:800px; background-color: #ffffff; margin-left: auto; margin-right: auto}
  2. column-one {display:none; width:0px;background-color: #ffffff;}
  3. content{ margin: 0 0 0 0;padding: 12px 12px 12px 12px; width:775px;border: 0;}
  4. bodyContent{ width: 730px; align: center; background-color: #ffffff;position:relative;left:20px;}
  5. column-content{width: 800px;background-color: #ffffff;}
  6. footer{position: center; width: 800px}

-->

</style> </head>

<body>

   <div id="top">	
     <figure>
       <div  class="Logo">
         <img src="http://openwetware.org/images/9/9c/Logo-OCKver.png" width=730px height=128px>
       </div>
     </figure>
   </div>
   <br>

<div class="sidebar">

 <ul>
    <li><a href="http://openwetware.org/wiki/Biomod/2013/Todai">Home</a>
    </li>
    <li><a href="http://openwetware.org/wiki/Biomod/2013/Todai/Project">Project</a>
    </li>
    <li><a href="http://openwetware.org/wiki/Biomod/2013/Todai/Design">Design</a>
    </li>
    <li><a href="http://openwetware.org/wiki/Biomod/2013/Todai/Result">Result</a>
    </li>
    <li><a href="http://openwetware.org/wiki/Biomod/2013/Todai/Experiment">Experiment</a>
       <ul style="list-style-type: none;">

<li>

          <a href="http://openwetware.org/wiki/Biomod/2013/Todai/Experiment#Contents">
          Contents</a></li>
          <li>
          <a href="http://openwetware.org/wiki/Biomod/2013/Todai/Experiment#PilotStudy">
          Pilot Study</a></li>
          <li>
          <a href="http://openwetware.org/wiki/Biomod/2013/Todai/Experiment#Protocols">
          Protocols</a></li>
       </ul>
    </li>
    <li><a href="http://openwetware.org/wiki/Biomod/2013/Todai/Team">Team</a>
    </li>
    <li><a href="http://openwetware.org/wiki/Biomod/2013/Todai/Sponsors">Sponsors</a>
    </li>
 </ul>

</div>


<div class="Return-Logo">

 <a href="#TOP">
   <figure>
     <img src="http://openwetware.org/images/b/b1/Return-top-0828new.png" width:60px height:60px>
   </figure>
 </a>

</div>

</body> </html>

<html> <head> <title>Project-Todai nanORFEVRE-</title> <style>

.project-list {

 font-size:130%;
 position:relative;
 left:30px;
 line-height:1.8;
 font-weight:bolder;
 color:#e00000;
 margin-bottom:15px;
 }

.project-list li {

 list-style:none;
 list-style:decimal;
 }

.rightbar-pro {

 font-size: 90%;
 width: 140px;
 background-color: #ffffff;
 padding: 5px;
 padding-left:2px;
 position: fixed;
 top: 250px;
 left: auto;
 z-index: 20;
 margin: 0 0 0 797px;
 border:solid 1.5px orange;
 }

.rightbar-pro ul {

 position:relative;
 top:-2px;
 line-height:1.5;
 }

.indetail-bac a{

 font-size:130%;
 font-weight:bolder;
 position:relative;
 left:300px;
 }

.indetail-sol a{

 font-size:130%;
 font-weight:bolder;
 position:relative;
 left:450px;
 }

figure.figure-left {

 position:relative;
 left:-35px;
 }

figure.figure-right {

 position:relative;
 left:35px;
 }

</style>

</head>

<body>

<!--rightbar--> <div class="rightbar-pro">

 <ul>
    <li><a href="#Background and problem">Background&amp;Problem</a>
    </li>
    <li><a href="#Solution">Solution</a>
    </li>
    <li><a href="#Project Goals">Project Goals</a>
    </li>
 </ul>

</div>


<!--Project-->

  <h1 class="big-title"><a name="Project">&nbsp;Project</a></h1>
  <br>

<!--BGP-->

  <article>
   <h1 class="title"><a name="Background and problem">&nbsp;Background and problem</a></h1>
   <br>

<!--paragraph1-->

 <article>
      <figure class="figure-left">
        <img style="float:left; margin:0;margin-right:-10px;margin-bottom:10px;"
        src="http://openwetware.org/images/e/e8/Bgp4-1-Todai.png" width="350px" height="272px" >
      </figure>
      <br>     
      <br>
      <p class="paragraph">

Cancer is one of the most common diseases in the world. Cancer cells divide abnormally and grow uncontrollably, resulting in the formation of malignant tumors, and invading human body. Cancer causes about 13 percent of the all human deaths worldwide (WHO 2007).

      </p>
      <br>
      <br>
      <br>
      <br>
      <br>
 </article>


<!--paragraph2-->

    <article>
       <figure class="figure-right">
         <img style="float:right;margin:0;margin-left:-10px;" 
         src="http://openwetware.org/images/d/d8/Bgp4-2-Todai.png" width="350px" height="272px" >
       </figure>
      <p class="paragraph">

Chemotherapy is a popular medical treatments for the cancer, however, it often attacks normal cells in addition to the cancer cells, damaging normal tissue and organs, which cause severe side effects. According to <a target="_blank" href="http://www.cancer.org/" style="color:#e00000;">the American cancer society</a>, these side effects include pain, vomiting, limphedemia, sexual decline and various symptoms, which seriously decrease quality of life.

      </p>
      <br>     
      <br>
      <br>
      <br>
  </article>

<!--paragraph3-->

    <article>
      <figure class="figure-left">
        <img style="float:left; margin-right:-10px; margin-left:0px;"
        src="http://openwetware.org/images/d/d0/Bgp4-3-Todai.png" width="350px" height="272px" >
      </figure>
      <br>
      <br>
      <br>

<!--paragraph4-->

      <p class="paragraph">
      To improve cancer-specificity, drug delivery system (DDS) has developed, but it is difficult to optimize a delivery system for each drug.
      </p>
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>
      <br>
    </article>

<!--paragraph4-->

    <article>
      <p class="paragraph" style="font-size:130%">
      Team Todai nanORFEVRE are trying to make <span style="font-weight:bolder;color:#e00000;">cancer-specific drug which doesn't need delivery system (DDS)</span>.
      </p>
      <br>
      <figure>
        <center>
          <img style="margin-top:0px;"
          src="http://openwetware.org/images/f/f2/Todai_project_back4.4.png" width=450px height=350px >
        </center>
      </figure>
    </article>
    <br>
  </article>
  <br>
  <br>
 
  

<!--Solution-->

  <article>
   <h1 class="title"><a name="Solution">&nbsp;Solution</a></h1>
   <br>

<!--paragraph1-->

    <article>
      <figure class="figure-left" style="position:relative;left:-40px;">
        <img style="float:left; margin-right:-20px; margin-left:0px;"
        src="http://openwetware.org/images/7/7f/Solution3-1-Todai.png" width="330px" height="257px" >
      </figure>
      <p class="paragraph" style="font-size:105%;">

To achieve a cancer-cell-killing system with high specificity, we first took attention to a mechanism in the human immune system called membrane attack complex (MAC), which operates when bacteria infect our body. In the system of MAC, subunits penetrate the membrane, oligomerize, and form a pore into the bacteria membrane. Then the subunits disrupt the lipid bilayer, inducing targeted cells lysis and death. The point of this system is that the subunits show cytotoxity only after forming a pore. MAC do not kill the cell simply by penetration, as molecules on the surface of harmless cells prevent MAC from sticking in (and forming pores). Therefore, MAC will only show cytotoxity to foreign cells such as bacteria.     </p>

       <br>
   </article>

<!--paragraph2-->

    <article>
      <p class="paragraph">

However, the target-recognition of MAC is far more complicated than referred above, in which a lot of molecules are related. So it is much difficult to mimic the whole system, leading us to take a simple synthetic biological approach.

      </p>
      <figure>
        <center>
          <img src="http://openwetware.org/images/f/f8/Todai_solution3.2.png" width=450px height=350px >
        </center>
      </figure>
    </article>
   <br>

<!--paragraph3-->

    <article>
      <p class="paragraph">

In the previous study, Rausch et al. used peptides to develop pore-forming proteins like MAC <span class="ref-sup"><a href="#proref-1">[1]</a></span>,but in that research they could not recognize the specific cells. To achieve the recognition system, we thought about using DNA. Recently, in situ computation by DNA was reported (Maria Rudchenko et al. (2013).<span class="ref-sup"><a href="#proref-2">[2]</a></span> In that study, DNA was used as logic circuits: using surface antigens as inputs and generating DNA strands as outputs. Rudchenko et al. said that it may be possible to use their logic circuit for other self-assembling systems and DNA machinery. We, therefore, thought that it might be possible to make cancer-recognition system using DNA. Inspired by cell recognizing molecular nano-robot study (Douglass et al. (2012)<span class="ref-sup"><a href="#proref-3">[3]</a></span>, we used <a href="http://openwetware.org/wiki/Biomod/2013/Todai/Design#2.2_Recognition_system" style="color:#e00000">DNA aptamer</a> to recognize cancer cells.

      </a> 
      </p>
      <br>
      <br>
   </article>

<!--paragraph4-->

    <article>
      <p class="paragraph">
Our general idea is explained as follows. 1) Subunits stick in normal and cancer cells nonspecifically. 2) In case that cancer-specific proteins exist, OCKs get able to oligomerize. 3)Then subunits oligomerize and form a pore, and cytotoxicity is induced to the cancer cell. Overall, our subunits may oligomerize only on the cancer cells and kill only cancer cells.
      </p>
      
      <p class="paragraph">

DNA itself has information embedded in the sequence. Using DNA computation and DNA-protein hybrid system, in which multiple molecules coordinate, we believe that our "Oligomeric Cell Killer" has the potential to treat cancer and other diseases like infection.

      </p>
      <br>
    <figure>
      <center>
        <img src="http://openwetware.org/images/c/c2/Todai_project_solution3.3.png" width=450px height=350px >
       </center>
     </figure>
   </article>
   <br>


 </article>
 <br>
 <br>

<!--ProjectGoals-->

  <article>
   <h1 class="title"><a name="Project Goals">&nbsp;Project Goals</a></h1>

<!--paragraph1-->

    <article>
      <p class="paragraph">
We set the creation of a prototype of<span style="color:#e00000"> the cancer-specific drug which doesn't need delivery system (DDS)</span> as the goal.To achieve this goal, we thought about biomolecular robotic system named as "Oligomeric Cell Killer" explained in <a target="_blank" href="http://openwetware.org/wiki/Biomod/2013/Todai/Design" style="color:#e00000">
      the Design page
      </a>.
      </p>
   </article>
   <br>

<!--paragraph2-->

    <article>
      <p class="paragraph">
      We can divide the project goal into following six steps.
      </p>
      <br>
    <ul class="project-list">
      <li>DNA strands assemble to form designed structures</li>
      <li>Penetration into the membrane</li>
      <li>Recognition of cancer-specific proteins</li>
      <li>Oligomerization in solution</li>
      <li>Oligomerization on the membrane</li>
	<li>Pore-formation and killing of the cell</li>
    </ul>
    <figure>
      <center>
        <img src=" http://openwetware.org/images/4/4f/Projectsteps.png " width="750px" height="500px" style="position:relative;left:-42px;" >
       </center>
     </figure>
    </article>
    <br>

<!--paragraph3-->

      <article>
      <p class="paragraph" style="font-size:110%;">
      We showed what we did in each step in 
      <a target="_blank" href="http://openwetware.org/wiki/Biomod/2013/Todai/Result"     
      style="color:#e00000">
      the Result page
      </a>.
      </p>
      </article>
      <br>
      <br>

<!--References-->

  <article>
    <h1 class="title"><a name="References">&nbsp;References</a></h1>
    <br>


    <div>     
       <div class="reference-title">
       <a name="proref-1">
       [1] Rational combinatorial design of pore-forming β-sheet peptides
       </a>
       </div>
          <div class="reference-author">
          Joshua M. Rausch, Jessica R. Marks, and William C. Wimley
          </div>
             <div class="reference-journal">
             PNAS 2005 102 (30) 10511-10515; published ahead of print July 14, 2005, doi:10.1073/pnas.0502013102
             </div>
    </div>
    <br>
    <div>     
       <div class="reference-title">
       <a name="proref-2">
       [2] Autonomous molecular cascades for evaluation of cell surfaces
       </a>
       </div>
          <div class="reference-author">
          Maria Rudchenko, Steven Taylor, Payal Pallavi, Alesia Dechkovskaia, Safana Khan, Vincent P. Butler Jr, Sergei Rudchenko &amp; Milan N. Stojanovic
          </div>
             <div class="reference-journal">
             Nature Nanotechnology 8, 580-586 (2013) doi:10.1038/nnano.2013.142
             </div>
    </div>

<br>

    <div>     
       <div class="reference-title">
       <a name="proref-3">
       [3]A logic-gated nanorobot for targeted transport of molecular payloads.
       </a>
       </div>
          <div class="reference-author">
         Shawn M. Douglas, Ido Bachelet and George M. Church
          </div>
             <div class="reference-journal">
           Science. 2012 Feb 17;335(6070):831-4. doi: 10.1126/science.1214081.
             </div>
    </div>
 </article>
  <br>
  <br>
  <br>
  <br>
  <br>
  <br>
  <br>
  <br>

<footer style="position:relative;left:400px"> <small> Copyright &copy; Todai nanORFEVRE, all rights reserved. </small> </footer></body> </html>